Summary
Results of chemotherapy in head and neck cancers are reported with a regimen of cisplatinum, bleomycin and methotrexate. In 63 previously untreated patients, the overall response rate was 73%, including 13/63 CR and 33/63 PR. The response rate in 20 previously treated tumors was 20%. The chemotherapy protocol was well tolerated without severe complications. Initial chemotherapy as a third modality in addition to radiotherapy and/or surgery is discussed.
This is a preview of subscription content, log in via an institution to check access.
References
Amrein PC, Weitzman SA (1985) Treatment of squamous cell carcinoma of the head and neck with cis-platinum and 5-fluorouracil. J Clin Oncol 3:1632–1639
Bassot V, Brasnu D, Lacau-St. Guily J, Fabre A, Menard M, Donnadieu S, Jacquillat U, Lacorreye H (1986) Chiothérapie d'induction dans les cancers des voies aérodigestives par perfusions continues associant cisplatinum, fluoro-5-uracilem bléomycine on C.F.. Ann Otolaryngol Chir Cervicofac 103:73–76
Böheim K, Spoendlin H (1985) Three-year results of combined modality therapy in locally advanced, resectable squamous cell carcinoma of the head and neck. Acta Otolaryngol 100:134
Coughlin CT, Grace M, O'Donnell J, Le Marbre PJ, Morain WD, Geurkink NA, McIntyre OR (1984) Combined modality approach in the management of locally advanced head and neck cancer. Cancer Treat Rep 68:591
Dasmahapatra KS, Citrin P, Hill G, Yee R, Mohit M, Rush B (1985) A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous cell carcinoma of the head and neck. J Clin Oncol 3:1486–1489
Decker DA, Drelichman A, Jacobs J, Hoschner J, Kinzie J, Loh JJ, Weaver A, Al-Sarraf M (1983) Adjuvant chemotherapy with cisplatinum and 120-h infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 51:1353–1355
Deitmer T, Urbanitz D (1986) Zytostatische Primärtherapie von Plattenepithelkarzinomen des Oro- und Hypopharynx mit Cisplatin, Bleomycin und Methotrexat. Laryngol Rhinol Otol (Stuttg) 65:7–10
Drelichman A, Cummings G, Al-Sarraf M (1983) A randomized trial of the combination of cis-platinum, oncovin and bleomycine versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck. Cancer 52:399–403
Ervin TJ, Weichselbaum RR, Fabian RL, Miller D, Norris CM, Posner MR, Rose C, Lockhart P, Tuttle SA, McIntyre JM, Frei E (1984) Advanced squamous carcinoma of the head and neck. Arch Otolaryngol 110:241–245
Kish JA, Ensley JF, Jacobs J, Weaver A, Cummings G, Al-Sarraf M (1985) A randomized trial of cis-platin+5-fluorouracil infusion and cis-platin+5 FU-bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56:2740–2744
Laccourreye H, Bassot V, Lacan J, Brasnu D, Menard M, Donnadieu S, Jacquillat C (1985) Chimiotherapie d'induction dans les cancers des voies aéro-digestives supérieures. Ann Oto-Laryngol Chir Cervicofax 102:1
Million RR, Cassisi NJ (1984) Management of head and neck Cancer. Lippincott Co., Philadelphia
Rooney M, Kish J, Jacobs J, Kinzie J, Weaver A, Crissmann J, Al-Sarraf M (1985) Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-h 5-FU infusion and cisplatin. Cancer 55:1123–1128
Schröder M, von Heyden HW, Scherpe A, Nagel GA (1986) Einfluß der Chemotherapie auf die Überlebenszeit von Patienten mit weit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches. Laryngol Rhinol Otol (Stuttg) 65:11–15
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deitmer, T., Urbanitz, D. Chemotherapy in head and neck cancer with bleomycin, cisplatinum, and methotrexate. J Cancer Res Clin Oncol 114, 644–646 (1988). https://doi.org/10.1007/BF00398192
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00398192